2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Renal Failure: new trials by email Literature Review of Renal Failure trials Research Report on Renal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment Lu AF35700 - Renal Failure | Phase 1 | Terminated | H. Lundbeck A/S | 23 | 2017-07-25 | 2019-09-30 |
| Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction Dabrafenib, Laboratory Biomarker Analysis, Pharmacogenomic Study - BRAF Gene Mutation, Hepatic Complication | Phase 1 | Terminated | National Cancer Institute (NCI) | 8 | 2013-08-23 | 2018-08-14 |
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2)
Lu AF35700 (1) · Pharmacogenomic Testing (1) · dabrafenib (1)
H. Lundbeck A/S (1) · National Cancer Institute (NCI) (1)
Canada (1) · Germany (1) · United States (1)
P30CA015083 (1), U01CA062490 (1), U01CA069912 (1), U01CA132123 (1), UM1CA186644 (1), UM1CA186686 (1), UM1CA186690 (1), UM1CA186691 (1), UM1CA186709 (1), UM1CA186716 (1), UM1CA186717 (1)